0001013762-23-006993.txt : 20231026 0001013762-23-006993.hdr.sgml : 20231026 20231026172012 ACCESSION NUMBER: 0001013762-23-006993 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231026 DATE AS OF CHANGE: 20231026 EFFECTIVENESS DATE: 20231026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495746 FILM NUMBER: 231351194 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE VA VIRGINIA 22901 (434) 422-9800 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true Cary J. Claiborne 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22902 Executive Officer Director Joseph M. Truluck 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James K. Anderson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Robertson H. Gilliland 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Bankole A. Johnson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James W. Newman, Jr. 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Kevin Schuyler, CFA 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Tony Goodman 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Pharmaceuticals Decline to Disclose 06b false 2023-10-19 false true true true false The Company issued pre-funded warrants, series A warrants and series B warrants , each warrant to purchase one share of common stock 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 NY NEW YORK false 3998582 3998582 0 true 0 1 320000 true 0 Includes placement agent fee of 7% & management fee of 1% of the aggregate gross proceeds of the offering. The issuer issued to placement agent designees warrants to purchase up to 85,106 shares at an exercise price of $3.25 and paid offering expenses 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false ADIAL PHARMACEUTICALS, INC. /s/ Cary J. Claiborne Cary J. Claiborne Chief Executive Officer 2023-10-26